Matches in SemOpenAlex for { <https://semopenalex.org/work/W2795384111> ?p ?o ?g. }
- W2795384111 endingPage "110" @default.
- W2795384111 startingPage "110" @default.
- W2795384111 abstract "The identification and study of genetic alterations involved in various signaling pathways associated with the pathogenesis of acute lymphoblastic leukemia (ALL) and the application of recent next-generation sequencing (NGS) in the identification of these lesions not only broaden our understanding of the involvement of various genetic alterations in the pathogenesis of the disease but also identify new therapeutic targets for future clinical trials. The present review describes the main deletions, amplifications, sequence mutations, epigenetic lesions, and new structural DNA rearrangements detected by NGS in B-ALL and T-ALL and their clinical importance for therapeutic procedures. We reviewed the molecular basis of pathways including transcriptional regulation, lymphoid differentiation and development, TP53 and the cell cycle, RAS signaling, JAK/STAT, NOTCH, PI3K/AKT/mTOR, Wnt/β-catenin signaling, chromatin structure modifiers, and epigenetic regulators. The implementation of NGS strategies has enabled important mutated genes in each pathway, their associations with the genetic subtypes of ALL, and their outcomes, which will be described further. We also discuss classic and new cryptic DNA rearrangements in ALL identified by mRNA-seq strategies. Novel cooperative abnormalities in ALL could be key prognostic and/or predictive biomarkers for selecting the best frontline treatment and for developing therapies after the first relapse or refractory disease." @default.
- W2795384111 created "2018-04-13" @default.
- W2795384111 creator A5003245494 @default.
- W2795384111 creator A5035896968 @default.
- W2795384111 creator A5041936963 @default.
- W2795384111 creator A5063715435 @default.
- W2795384111 creator A5074746066 @default.
- W2795384111 date "2018-04-07" @default.
- W2795384111 modified "2023-10-04" @default.
- W2795384111 title "New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update" @default.
- W2795384111 cites W1770669347 @default.
- W2795384111 cites W182778883 @default.
- W2795384111 cites W1920376293 @default.
- W2795384111 cites W1931130202 @default.
- W2795384111 cites W1953576910 @default.
- W2795384111 cites W1969979664 @default.
- W2795384111 cites W1971176522 @default.
- W2795384111 cites W1971455609 @default.
- W2795384111 cites W1972362842 @default.
- W2795384111 cites W1982984451 @default.
- W2795384111 cites W1986462796 @default.
- W2795384111 cites W1986495031 @default.
- W2795384111 cites W1989949054 @default.
- W2795384111 cites W1991358041 @default.
- W2795384111 cites W1992477322 @default.
- W2795384111 cites W1993391636 @default.
- W2795384111 cites W1994504883 @default.
- W2795384111 cites W1995460052 @default.
- W2795384111 cites W1997565067 @default.
- W2795384111 cites W1998874936 @default.
- W2795384111 cites W2000589976 @default.
- W2795384111 cites W2002159154 @default.
- W2795384111 cites W2006631524 @default.
- W2795384111 cites W2014889002 @default.
- W2795384111 cites W2025462312 @default.
- W2795384111 cites W2029985772 @default.
- W2795384111 cites W2030899725 @default.
- W2795384111 cites W2033091093 @default.
- W2795384111 cites W2037690521 @default.
- W2795384111 cites W2039616075 @default.
- W2795384111 cites W2040329520 @default.
- W2795384111 cites W2045829112 @default.
- W2795384111 cites W2047965845 @default.
- W2795384111 cites W2048983861 @default.
- W2795384111 cites W2049396238 @default.
- W2795384111 cites W2049865207 @default.
- W2795384111 cites W2052909547 @default.
- W2795384111 cites W2053694886 @default.
- W2795384111 cites W2054097400 @default.
- W2795384111 cites W2056171219 @default.
- W2795384111 cites W2057602257 @default.
- W2795384111 cites W2060605982 @default.
- W2795384111 cites W2063662864 @default.
- W2795384111 cites W2069709802 @default.
- W2795384111 cites W2076584338 @default.
- W2795384111 cites W2077546113 @default.
- W2795384111 cites W2082756899 @default.
- W2795384111 cites W2092765992 @default.
- W2795384111 cites W2101940280 @default.
- W2795384111 cites W2103420336 @default.
- W2795384111 cites W2108525773 @default.
- W2795384111 cites W2110523744 @default.
- W2795384111 cites W2112783848 @default.
- W2795384111 cites W2113231429 @default.
- W2795384111 cites W2114340167 @default.
- W2795384111 cites W2116823767 @default.
- W2795384111 cites W2119323978 @default.
- W2795384111 cites W2137042680 @default.
- W2795384111 cites W2137972975 @default.
- W2795384111 cites W2138928429 @default.
- W2795384111 cites W2140154966 @default.
- W2795384111 cites W2145968395 @default.
- W2795384111 cites W2150116340 @default.
- W2795384111 cites W2153272770 @default.
- W2795384111 cites W2158026056 @default.
- W2795384111 cites W2160959653 @default.
- W2795384111 cites W2169498754 @default.
- W2795384111 cites W2170959495 @default.
- W2795384111 cites W2253056939 @default.
- W2795384111 cites W2269706733 @default.
- W2795384111 cites W2302459081 @default.
- W2795384111 cites W2321589388 @default.
- W2795384111 cites W2337104547 @default.
- W2795384111 cites W2339215362 @default.
- W2795384111 cites W2339658711 @default.
- W2795384111 cites W2342789489 @default.
- W2795384111 cites W2347120871 @default.
- W2795384111 cites W2351547314 @default.
- W2795384111 cites W2405657090 @default.
- W2795384111 cites W2406122148 @default.
- W2795384111 cites W2474804728 @default.
- W2795384111 cites W2507670193 @default.
- W2795384111 cites W2521847134 @default.
- W2795384111 cites W2548804135 @default.
- W2795384111 cites W2549643332 @default.
- W2795384111 cites W2551231092 @default.
- W2795384111 cites W2554700296 @default.
- W2795384111 cites W2555713721 @default.